AAAAAA

   
Results: 1-8 |
Results: 8
CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV)
Authors: Hancock, GE Heers, KM Smith, JD Scheuer, CA Ibraghimov, AR Pryharski, KS
Citation: Ge. Hancock et al., CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV), VACCINE, 19(32), 2001, pp. 4874-4882
Adaptive immune responses of patients with asthma to the attachment (G) glycoprotein of respiratory syncytial virus
Authors: Hancock, GE Scheuer, CA Sierzega, R Pryharski, KS McBride, JT Watelet, LFM Tebbey, PW Smith, JD
Citation: Ge. Hancock et al., Adaptive immune responses of patients with asthma to the attachment (G) glycoprotein of respiratory syncytial virus, J INFEC DIS, 184(12), 2001, pp. 1589-1593
QS-21 synergizes with recombinant interleukin-12 to create a potent adjuvant formulation for the fusion protein of respiratory syncytial virus
Authors: Hancock, GE Heers, KM Smith, JD
Citation: Ge. Hancock et al., QS-21 synergizes with recombinant interleukin-12 to create a potent adjuvant formulation for the fusion protein of respiratory syncytial virus, VIRAL IMMUN, 13(4), 2000, pp. 503-509
The immunogenicity of subunit vaccines for respiratory syncytial virus after co-formulation with aluminum hydroxide adjuvant and recombinant interleukin-12
Authors: Hancock, GE Smith, JD Heers, KM
Citation: Ge. Hancock et al., The immunogenicity of subunit vaccines for respiratory syncytial virus after co-formulation with aluminum hydroxide adjuvant and recombinant interleukin-12, VIRAL IMMUN, 13(1), 2000, pp. 57-72
Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H
Authors: Tebbey, PW Scheuer, CA Peek, JA Zhu, DZ LaPierre, NA Green, BA Phillips, ED Ibraghimov, AR Eldridge, JH Hancock, GE
Citation: Pw. Tebbey et al., Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H, VACCINE, 18(24), 2000, pp. 2723-2734
Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice
Authors: van Schaik, SM Obot, N Enhorning, G Hintz, K Gross, K Hancock, GE Stack, AM Welliver, RC
Citation: Sm. Van Schaik et al., Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice, J MED VIROL, 62(2), 2000, pp. 257-266
Serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines coformulated with natural fusion and attachment proteins of respiratory syncytial virus
Authors: Hancock, GE Smith, JD Heers, KM
Citation: Ge. Hancock et al., Serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines coformulated with natural fusion and attachment proteins of respiratory syncytial virus, J INFEC DIS, 181(5), 2000, pp. 1768-1771
A novel and effective intranasal immunization strategy for respiratory syncytial virus
Authors: Tebbey, PW Unczur, CA LaPierre, NA Hancock, GE
Citation: Pw. Tebbey et al., A novel and effective intranasal immunization strategy for respiratory syncytial virus, VIRAL IMMUN, 12(1), 1999, pp. 41-45
Risultati: 1-8 |